SHC1 and neoplasm: Tumour vaccination strategies modestly impacted the tumorigenic potential of MT/ShcA+/+ tumours (30% tumour free) and ablated MT/Shc2F/2F tumour initiation (100% tumour free) even 3 months post tumour cell inoculation (Fig. 6b).